Clinical Trials
2 trialsNCT03745716 2025-03-18
APR-246 & Azacitidine for the Treatment of TP53 Mutant Myelodysplastic Syndromes (MDS)
Aprea Therapeutics
Phase 3 Completed
NCT06267898 2024-02-20
Non Interventional Study on Iron Toxicity After First Allo-transplant in MDS/CMML
European Society for Blood and Marrow Transplantation
Completed